{"id":"11c20aaf-d7ca-5192-9c43-ab27c3e0fb65","stable_key":"0ad8610d-d575-5870-b7cd-763a9f750783:copper-elesclomol-intestinal-bypass","predicate":"rescues_transport_defect_in_mice","statement":"Oral elesclomol without extra copper supplementation rescued neonatal mortality in intestine-specific Ctr1 knockout mice.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"d766b829-f568-5687-b67b-56d1931b0c56","mechanism_event_label":"The drug helped use existing dietary copper despite a missing intestinal entry route.","subject":{"id":"a3d8d3f7-229d-5cd7-8c69-64bdd95d1f03","slug":"elesclomol","display_name":"Elesclomol","entity_type_key":"small_molecule"},"object":{"id":"979842b5-a055-50fa-806d-c8254b050470","slug":"systemic-copper-delivery","display_name":"Delivery of intestinal copper to peripheral tissues","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"d766b829-f568-5687-b67b-56d1931b0c56","stable_key":"0ad8610d-d575-5870-b7cd-763a9f750783:copper-elesclomol-intestinal-bypass-event","event_type":"biochemical_relationship","label":"The drug helped use existing dietary copper despite a missing intestinal entry route.","description":"Oral elesclomol without extra copper supplementation rescued neonatal mortality in intestine-specific Ctr1 knockout mice.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"9b443d47-b3cc-538d-ad34-e93b5c7880c8","slug":"mouse-slc31a1","display_name":"Mouse copper transporter Ctr1 / Slc31a1","entity_type_key":"protein"},"role":"deleted intestinal transporter","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"a3d8d3f7-229d-5cd7-8c69-64bdd95d1f03","slug":"elesclomol","display_name":"Elesclomol","entity_type_key":"small_molecule"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"979842b5-a055-50fa-806d-c8254b050470","slug":"systemic-copper-delivery","display_name":"Delivery of intestinal copper to peripheral tissues","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/copper-research/35433682.abstract.txt\", \"locator\": \"Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"6ebf1fdc967be53f455383e4edc79468266a5685db3867ca04ce2e2ccc4f2617\", \"start_char\": 0, \"end_char\": 1449, \"text_sha256\": \"6ebf1fdc967be53f455383e4edc79468266a5685db3867ca04ce2e2ccc4f2617\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Oral elesclomol in genetically copper-transport-defective animals","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Oral drug exposure without additional copper supplementation","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Animal rescue does not establish safety or efficacy in people. Intestinal CTR1 loss is a different block from mitochondrial SLC25A3 loss.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Copper research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"copper","display_name":"Copper","entity_type_key":"nutrient_element"}},{"dimension":"organism","value_text":"Mouse; separate Caenorhabditis elegans experiments","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"The drug helped use existing dietary copper despite a missing intestinal entry route.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[copper-p35433682] Oral Elesclomol Treatment Alleviates Copper Deficiency in Animal Models. (2022). https://pubmed.ncbi.nlm.nih.gov/35433682/ DOI: 10.3389/fcell.2022.856300","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Intestine and whole-animal development","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"dc8cdb50-90ed-5a71-ba16-ee3ca4444e1d","evidence_kind":"source_excerpt","locator":"Lines 598-609","start_line":598,"end_line":609,"excerpt":"### copper-elesclomol-intestinal-bypass\nOral elesclomol without extra copper supplementation rescued neonatal mortality in intestine-specific Ctr1 knockout mice.\nCondition category: machinery_impairment\nnutrient_topic: Copper research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: The drug helped use existing dietary copper despite a missing intestinal entry route.\norganism: Mouse; separate Caenorhabditis elegans experiments\ntissue_or_cell_type: Intestine and whole-animal development\nexperimental_model: Oral elesclomol in genetically copper-transport-defective animals\nlimitations: Animal rescue does not establish safety or efficacy in people. Intestinal CTR1 loss is a different block from mitochondrial SLC25A3 loss.\nexposure: Oral drug exposure without additional copper supplementation\nevidence_span: {\"source_cache\": \"artifacts/copper-research/35433682.abstract.txt\", \"locator\": \"Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"6ebf1fdc967be53f455383e4edc79468266a5685db3867ca04ce2e2ccc4f2617\", \"start_char\": 0, \"end_char\": 1449, \"text_sha256\": \"6ebf1fdc967be53f455383e4edc79468266a5685db3867ca04ce2e2ccc4f2617\"}\n[copper-p35433682] Oral Elesclomol Treatment Alleviates Copper Deficiency in Animal Models. (2022). https://pubmed.ncbi.nlm.nih.gov/35433682/ DOI: 10.3389/fcell.2022.856300","model_system":"Oral elesclomol in genetically copper-transport-defective animals","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [copper-p35433682] Oral Elesclomol Treatment Alleviates Copper Deficiency in Animal Models. (2022). https://pubmed.ncbi.nlm.nih.gov/35433682/ DOI: 10.3389/fcell.2022.856300","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"9afba495-cbdc-51aa-998e-70a930dba3be","stable_key":"import-0ad8610d-d575-5870-b7cd-763a9f750783","title":"Copper: transport, cuproenzymes, deficiency, excess and nutrient interactions (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"84b0f62b2dae6835fa26902be87625c003c6c707492d3007e8f9d15420669008","revision_id":"d7e35b8b-3f77-56d9-90b5-5f542c63f321","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}